Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Complement component C5a is a potent, 74-amino acid glycoprotein fragment (~11 kDa) generated by the enzymatic cleavage of complement component C5 by C5 convertase. It acts as a highly inflammatory peptide with multiple roles in immune regulation and inflammation, functioning as both an anaphylatoxin and a chemotactic agent.
C5a exerts its effects primarily through binding two G protein-coupled receptors: C5aR1 (CD88) and C5L2 (GPR77), triggering intracellular signaling cascades involving G proteins, β-arrestin recruitment, ERK1/2 phosphorylation, and calcium mobilization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement component C5a.